Hormonal maintenance therapy may improve survival in women with chemo-resistant rare ovarian or peritoneum cancer
Wednesday, February 22, 2017 - 10:31
in Health & Medicine
For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance therapy (HMT) may significantly improve survival, according to a new study.